Cargando…

Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?

Inflammatory bowel disease (IBD) is a multisystemic disease with a wide range of extraintestinal manifestations in both ulcerative colitis and Crohn’s disease, while increasing evidence supports the interaction between gut and central nervous system, described as “gut-brain axis”. According to epide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fousekis, Fotios S., Katsanos, Aristeidis H., Kourtis, Georgios, Saridi, Maria, Albani, Eleni, Katsanos, Konstantinos H., Christodoulou, Dimitrios K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510650/ https://www.ncbi.nlm.nih.gov/pubmed/34691320 http://dx.doi.org/10.14740/jocmr4593

Ejemplares similares

The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease
por: Fousekis, Fotios S., et al.
Publicado: (2022)

Ear Involvement in Inflammatory Bowel Disease: A Review of the Literature
por: Fousekis, Fotios S., et al.
Publicado: (2018)

Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
por: Politis, Dimitrios S, et al.
Publicado: (2019)

Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018)

Pancreatic Involvement in Inflammatory Bowel Disease: A Review
por: Fousekis, Fotios S., et al.
Publicado: (2018)

Alcohol and narcotics use in inflammatory bowel disease
por: Mantzouranis, George, et al.
Publicado: (2018)

Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review
por: Fousekis, Fotios S., et al.
Publicado: (2018)

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017)

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Current noninvasive modalities in Crohn’s disease monitoring
por: Mitselos, Ioannis V., et al.
Publicado: (2021)

Irritable bowel syndrome might be associated with dry eye disease
por: Asproudis, Ioannis, et al.
Publicado: (2016)

Medical, Endoscopic and Surgical Management of Stricturing Crohn’s Disease: Current Clinical Practice
por: Fousekis, Fotios S., et al.
Publicado: (2022)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Biomarker Development in Chronic Inflammatory Diseases
por: Katsanos, Aristeidis H., et al.
Publicado: (2017)

Psoriasis and inflammatory bowel disease: links and risks
por: Vlachos, Christoforos, et al.
Publicado: (2016)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Grading acute radiation bowel injury an unaddressed issue
por: Katsanos, Konstantinos H., et al.
Publicado: (2012)

Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease
por: Kosmidou, Maria, et al.
Publicado: (2020)

Fast-track drug approval in inflammatory bowel diseases
por: Katsanos, Konstantinos H., et al.
Publicado: (2016)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease?
por: Schembri, John, et al.
Publicado: (2017)

Strongyloides stercoralis infection: an “exotic” cause of chronic diarrhea
por: Politis, Dimitrios S., et al.
Publicado: (2017)

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

On the trail of cerebral sinus venous events in inflammatory bowel diseases
por: Kosmidou, Maria, et al.
Publicado: (2013)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Mental health among clinicians: what do we know and what can we do?
por: Patel, Mittal, et al.
Publicado: (2021)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Important advances in stroke research in 2020
por: Tsivgoulis, Georgios, et al.
Publicado: (2021)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature
por: Skamnelos, Alexandros, et al.
Publicado: (2015)

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?
por: Resál, Tamás, et al.
Publicado: (2021)

Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
por: Katsanos, Konstantinos H., et al.
Publicado: (2017)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glnmcphv044e3tbe6cgic3ra38